Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
GC Biopharma and Novelty Nobility Enter into Joint Research and Development Agreement for Geographic Atrophy Therapies
2024-10-29 09:13
GC Biopharma and Hanmi Pharmaceutical Receives IND Clearance for Phase 1/2 Clinical Trial from the U.S. FDA
2024-09-03 15:59
GC Cell Signs an MOU with PT Bifarma Adiluhung, an affiliate of KALBE group
2024-06-20 08:44
FDA Grants Fast Track Designation to GCBP and Novel Pharma's GC1130A
2024-06-10 16:18
GCBP Sponsors 2024 Spring Symposium for KASBP and Present Research Findings
2024-06-04 13:00
GC Cell participates 2024 BIO International Convention, Unveiling its future Blueprint 2.0, as the First Korean Business Forum Sponsor
2024-05-28 23:00
GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Clearance
2024-05-21 15:12
GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Approval
2024-05-20 14:07
GC Cell to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024
2024-04-02 23:00
GC Cell and BioCentriq® Execute Process Transfer Agreement in Anticipation of the U.S. entry of Immuncell-LC Inj.
2024-02-26 21:30
GC Biopharma Presents Updates on its LSD Treatments at the WORLDSymposium 2024
2024-02-14 16:33
European Medicines Agency (EMA) Grants Orphan Drug Designation (ODD) to GC Biopharma's Treatment for Sanfilippo Syndrome (Type A)
2024-01-23 11:53
GC Cell's Promising AB-201 Cancer Treatment to Begin Phase 1 Trials Using Lunit AI Platform
2024-01-09 00:00
GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI)
2023-12-18 09:49
GC Biopharma's groundbreaking for the plasma fractionation plant in Indonesia
2023-12-06 08:56
GC Biopharma establishes mRNA production facility in Hwasun, Korea
2023-12-01 16:31
The World's First "Recombinant Anthrax Vaccine": GC Biopharma applies for MFDS Approval
2023-11-06 09:11
GC Biopharma Shares its Successful HR System Transformation at SAP Success Connect 2023
2023-10-11 08:49
GC Biopharma Signs Power Purchase Agreement with SK E&S
2023-10-10 14:20
FDA Grants Orphan Drug Designation to GC Biopharma's Drug Candidate for Thrombotic Thrombocytopenic Purpura
2023-10-06 08:12
1
2
3